Take Mydipin 5 mg Tablet orally, once daily, with or without food. Swallow the tablet whole with water. Do not crush or chew.

Mydipin inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. This causes vasodilation, primarily in peripheral arterioles, leading to a reduction in peripheral vascular resistance and blood pressure. In angina, it increases myocardial oxygen delivery by dilating coronary arteries and reduces myocardial oxygen demand by reducing afterload.

• •Hypersensitivity to Mydipin or other dihydropyridines
• •Severe hypotension
• •Cardiogenic shock
• •Clinically significant aortic stenosis
• •Unstable angina or acute myocardial infarction

Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

Symptoms of overdose include excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. Management involves supportive measures, including monitoring cardiac and respiratory function, elevation of extremities, and administration of IV fluids. Vasopressors may be used if hypotension remains unresponsive to fluid resuscitation. Intravenous calcium gluconate may be beneficial.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Mydipin is excreted in human milk; caution should be exercised when administered to a nursing mother.